Synapse - Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial

Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial Meeting Abstract

Authors:	Mercade, T. M.; Bekaii-Saab, T.; Feeney, K.; Pant, S.; Park, J. O.; O'Reily, E. M.; Prager, G.; Seufferlein, T.; Boakye, M.; He, X.; Khemka, V.; Ueno, M.; Wainberg, Z. A.
Abstract Title:	Quemliclustat and chemotherapy in previously untreated patients with metastatic pancreatic ductal adenocarcinoma: PRISM-1, a randomized, placebo-controlled, phase III trial
Meeting Title:	Ann. Oncol.
Journal Title:	Annals of Oncology
Volume:	36
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2025-07-01
Language:	English
ACCESSION:	WOS:001545624000054
DOI:	10.1016/j.annonc.2025.05.399
PROVIDER:	wos
Notes:	Meeting Abstract -- 1 -- Source: Wos